Keefe, Bruyette & Woods Upgrades CME Group to Outperform, Maintains Price Target to $305

سي إم إي إنك

CME Group Inc. Class A

CME

0.00

Keefe, Bruyette & Woods analyst Chris Allen upgrades CME Group (NASDAQ: CME) from Market Perform to Outperform and maintains the price target from $305 to $305.